新開源(300109.SZ):選舉任大龍擔任副董事長
格隆匯 2 月 24日丨新開源(300109.SZ)公佈,公司董事會於近日收到公司副董事長趙威的書面辭職報吿,趙威因工作原因申請辭去公司副董事長職務,辭去上述職務後,其繼續擔任公司董事,辭職報吿自送達董事會之日起生效。
根據《公司法》等相關法律和公司章程的規定,結合公司實際情況,2021年2月23日召開了第四屆董事會第二十一次會議,審議通過了《關於選舉公司副董事長的議案》,公司董事會同意選舉任大龍擔任公司第四屆董事會副董事長,任期自本次董事會審議通過之日起至第四屆董事會屆滿時止。任大龍先生簡歷見附件。
任大龍,男,1970年出生,中國國籍,無永久境外居留權,本科學歷,工學學士。2000年至2006年,就職於北京華美傑潤石油新技術開發有限公司,擔任總經理;2006年創立武漢呵爾醫療科技發展有限公司並擔任董事長,現擔任新開源董事一職。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.